Author:
Shah Syed Zahid Ali,Zhao Deming,Taglialatela Giulio,Khan Sher Hayat,Hussain Tariq,Dong Haodi,Lai Mengyu,Zhou Xiangmei,Yang Lifeng
Funder
National Natural Science Foundation of China
Ministry of Agriculture of the People's Republic of China
The Foundation of Chinese Ministry of Science and Technology
Chinese Universities Scientific Fund
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Clinical Neurology,Pharmacology
Reference84 articles.
1. Nakagaki, Takehiro; Satoh., et al., FK506 reduces abnormal prion protein through the activation of autolysosomal degradation and prolongs survival in prion-infected mice. Autophagy, 2013. 9(9): p. 1386-94.
2. Puig Berta, Hermann C. Altmeppen, Sarah Ulbrich et al., Secretory pathway retention of mutant prion protein induces p38-MAPK activation and lethal disease in mice. Scientific Reports, 2016. 6(24970): p. 1-14.
3. Mukherjee Abhisek, Diego Morales-Scheihing, Dennisse Gonzalez-Romero ., et al., Calcineurin inhibition at the clinical phase of prion disease reduces neurodegeneration, improves behavioral alterations and increases animal survival. PLoS Pathog, 2010. 6(10): p. e1001138.
4. Mukherjee, A. and C. Soto, Role of calcineurin in neurodegeneration produced by misfolded proteins and endoplasmic reticulum stress. Curr Opin Cell Biol, 2011. 23(2): p. 223-30.
5. Song ZhiQi, Ting Zhu, Xiangmei Zhou et al., REST alleviates neurotoxic prion peptide-induced synaptic abnormalities, neurofibrillary degeneration and neuronal death partially via LRP6-mediated Wnt-β-catenin signaling. Oncotarget, 2016. 7(11): p. 12035-12052.
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献